Early Relapse Risk in Newly Diagnosed Multiple Myeloma Patients Characterized by Next-Generation Sequencing.
CONCLUSION: Early PD identifies a high-risk MM population. Further research is needed to better identify baseline features predicting early PD and the optimal treatment approaches for patients at risk.
PMID: 32616499 [PubMed - as supplied by publisher]
Source: Clinical Cancer Research - Category: Cancer & Oncology Authors: D'Agostino M, Zaccaria GM, Ziccheddu B, Rustad EH, Genuardi E, Capra A, Oliva S, Auclair D, Yesil J, Colucci P, Keats JJ, Gambella M, Bringhen S, Larocca A, Boccadoro M, Bolli N, Maura F, Gay F Tags: Clin Cancer Res Source Type: research
More News: Cancer | Cancer & Oncology | Myeloma | Stem Cell Therapy | Stem Cells | Study | Translocation | Transplants